App-Quantinova.ai

Improving Monitoring Outcomes and Quality of Life for Heart Failure Patients in Telehomecare Program

Yeva Sahakyan - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Mofezolac

Increasing QRS Duration Over Time Is Associated with Mortality and Morbidity in an Outpatient Heart Failure Population

William F McIntyre - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Mitral valve regurgitation

N/A

Double or Compound Sarcomere Mutations in Hypertrophic Cardiomyopathy is Not Associated with Worsened Outcomes: A Single Center Cohort Study

Ghadeera Almansoori - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypertrophic cardiomyopathy

N/A

The Impact of B-type Natriuretic Peptide Activation on the Association of Left Ventricular Longitudinal Strain with All-cause Mortality

Maurice Enriquez-Sarano - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

Sex Differences in Severe Pulmonary Arterial Hypertension Produced by SU5416 in a Colony of Hyper-responsive Sprague Dawley Rats

Ketul R Chaudhary - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Alora

The Prognostic Value of Insulin-like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction: Results From Irbesartan in Heart Failure and Preserved Ejection Fraction (I-PRESERVE) Trial

Thomas S. Rector - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with preserved ejection fraction

Irbesartan

Divergent Actions of Circulating Angiopoietin-2 on Vascular Inflammation and Leak in a Mouse Model of Acute Lung Injury

Mohamad Taha - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute lung injury

N/A

Unraveling Outcomes in Medically Managed Patient with Acute Coronary Syndromes (ACS): The Alberta COntemporary Acute coronary syndrome Patients invasive Treatment Strategies (COAPT) Study

Kevin R Bainey - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Desirudin

Coronary Fibromuscular Dysplasia Angiographic Manifestations

Jacqueline Saw - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Spontaneous coronary artery dissection

N/A

The Gap Between Indicated and Prescribed Stroke Prevention Therapies in A High-risk Geriatric Population in Ontario

Eugene Crystal - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

rivaroxaban

Maternal and Fetal Outcomes Among Pregnant Women with Frequent Premature Ventricular Complexes

Marc W Deyell - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Premature ventricular complexes

N/A

Renal Sympathetic Denervation Modulates Cardiac Repolarization in a Post Myocardial Infarction Pig Model

Sigfus Gizurarson - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

High-risk Plaque Co-localizes with Low Endothelial Shear Stress and Expansive Remodeling in Human Coronary Arteries: A 3D Optical Coherence Tomography Study

Konstantinos Toutouzas - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Impact on Clinical Outcomes of Randomization at Community Hospitals versus Pre-hospital Location in STEMI Patients: Insights From the STREAM Study

Patrick Goldstein - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Sudden Cardiac Death After Acute Heart Failure Hospitalization: Insights From ASCEND-HF

Sana M Al-Khatib - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic obstructive pulmonary disease

N/A

Mineralocorticoid Receptor Antagonist Utilization in Eligible Patients Post St-elevation Myocardial Infarction

Krishnan Ramanathan - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Myocardial infarction

N/A

Normalization of Renal AT1 Receptor Expression is Observed with Enalapril but Not Diltiazem in a Rat Model of Chronic Kidney Disease

Rob A deKemp - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chronic kidney disease

Angiotensin II

Vicious Circle Between Progressive Right Ventricular Dilatation and Pulmonary Regurgitation in Patients After Tetralogy of Fallot Repair? Right Heart Enlargement Promotes Flow Reversal in the Left Pulmonary Artery

Christian Drolet - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary regurgitation

N/A

Mechanism of Branch Pulmonary Artery Stenosis After the Arterial Switch Operation

Luc Mertens - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

The Modified History in Young Patients with Repaired Tetralogy of Fallot: A Longitudinal Magnetic Resonance Study

Bernadette Elders - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Filters

28841 Abstracts